Regulus Therapeutics Inc (NASDAQ:RGLS)

16.92
BATS BZX Real-Time Price
As of 10:44am ET
 +0.10 / +0.59%
Today’s Change
5.40
Today|||52-Week Range
25.60
+5.49%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 33.00, with a high estimate of 41.00 and a low estimate of 25.00. The median estimate represents a +95.04% increase from the last price of 16.92.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$2.1M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 44.15%
 
 
 
 
 
 
Growthannually 19.68%
 
 
 
 
 

Sales

Growthquarterly -49.95%
 
 
 
 
 
 
Growthannually 107.57%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account